Lehigh Valley Health Network

LVHN Scholarly Works
USF-LVHN SELECT

Systematic Review of the Delivery of Mydriacyl to
the Inpatient Pediatric Floors at LVHN for an
Ophthalmology Consultation.
Christopher Barron
USF MCOM- LVHN Campus, Christopher.Barron@lvhn.org

Follow this and additional works at: http://scholarlyworks.lvhn.org/select-program
Part of the Medical Education Commons
Published In/Presented At
Barron, C. (2017, March). Systematic Review of the Delivery of Mydriacyl to the Inpatient Pediatric Floors at LVHN for an Ophthalmology
Consultation. Poster Presented at: 2017 SELECT Capstone Posters and Presntations Day. Kasych Family Pavilon, Lehigh Valley Health
Network, Allentown, PA.

This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.

Systematic Review of the Delivery of Mydriacyl to the
Inpatient Pediatric Floors at LVHN for an Ophthalmology
Consultation
Christopher Barron
Lehigh Valley Health Network, Allentown, PA

Introduction

Results

For a hospital to operate within its
budget, it must offer efficient and
expedient services. In order to provide
quality, yet affordable care, a hospital
must be efficient in its practices. It
must provide the right treatment, at the
right time because there is an associated
opportunity costs with diagnosis and
treatment errors and delays (failure
modalities). Medication delivery is an
integral system to a well-functioning
hospital—it must be quick and most
importantly, correct.

Using the Institute of Healthcare Improvement (IHI) Failure Modalities and Effects Analysis,
this cross sectional study interviewed and surveyed teams and individuals to answer three
questions: what could go wrong? Why would the failure happen? and What would be the
consequences of each failure? Interviewees of representative of pharmacy and pediatric
nursing assigned numbers (1-10) for each of the questions asked, and a Risk Priority Number
(RPN) was calculated for each failure modality which is used to prioritize the modality that
needs to be assessed first, and with the most priority. The results, for the pharmacy and
nursing teams are listed below. The higher the RPN, the potentially more serious the failure
modality, and should be addressed first.

Failure Modalities and Occurence, Detection, Severity & RPN
for Tropicamide Delivery Process per Nursing Team

Problem Statement
After detailing the medication delivery
process of the ophthalmic drug,
Tropicamide, to the Pediatrics Floor at
the Lehigh Valley Health Network, this
study aims to identify where and how
the process might fail and to assess the
relative impact of different failures, in
order to identify the parts of the process
that are most in need of change.
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Failure Modalities and Occurence, Detection, Severity & RPN
for Tropicamide Delivery Process per Pharmacy Team
Misplaced
Time Delay
Delivered to Wrong Pt
Wrong Drug
Wrong Dose

Occurrence

Detection

Severity

RPN

2
1
1
1
1

6
5
2
2
2

7
5
9
8
6

84
25
18
16
12

Discussion
Of note, both pharmacy and nursing teams made suggestions that the delivery process of
tropicamide could be improved by permanently keeping tropicamide stocked in the Pyxis
units on the floors, and ultimately creating a stand alone pediatric pharmacy that is separate
from the main hospital pharmacy. With regards to Pyxis, both teams felt that there was
enough free space in the device that could store the tropicamide drops. They felt that this
would ensure a quicker, and more efficient delivery process, by bypassing the pharmacy
collection and distribution process. Additionally, both units felt that to minimize any potential
errors to the pediatrics floors, a pediatric stand alone pharmacy should be created. This
would allow for a reduction of errors and an decrease in transit time because it would be
streamlined for pediatric, not adult patient, needs.

Conclusions
THE IHI FMEA tool per nursing and pharmacy teams identified several failure modalities and
the RPNs associated with each modality. Misplacing Tropicamide was calculated to have
the highest RPN for both sub groups. Upon further questioning, both pharmacy and nursing
stated that it is the most likely to occur of all of the modalities and that it is the hardest
to detect (ie find the misplaced drops). This in turn can related to delay in delivery of the
dilating drops which is a delay in patient care. It also represents an opportunity cost to the
consultant. Moroever, this project also provided suggestions on how to improve the process,
most notably, consider stocking tropicamide in the Pyxis units on the floors.
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